Habibollahi et al., 2019 - Google Patents
Severe complications of tramadol overdose in IranHabibollahi et al., 2019
View HTML- Document ID
- 3079048738254427891
- Author
- Habibollahi P
- Garjani A
- Vahdati S
- Sadat-Ebrahimi S
- Parnianfard N
- Publication year
- Publication venue
- Epidemiology and health
External Links
Snippet
OBJECTIVES Severe complications of tramadol overdose have been reported; however, few large-scale studies have investigated this issue. Therefore, this study aimed to explore the presentation and complications of tramadol overdose in patients admitted to an intoxication …
- 229960004380 Tramadol 0 title abstract description 102
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epihephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Habibollahi et al. | Severe complications of tramadol overdose in Iran | |
| Thiele et al. | Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial | |
| Shekarchizadeh et al. | Oral health of drug abusers: a review of health effects and care | |
| Ghane et al. | Lead poisoning outbreak among opium users in the Islamic Republic of Iran, 2016–2017 | |
| Davidson et al. | Inhibition of complement in Guillain‐Barré syndrome: the ICA‐GBS study | |
| Wiffen et al. | Lamotrigine for acute and chronic pain | |
| Wilson et al. | The abuse potential of propofol | |
| Ohta et al. | Efficacy and safety of omalizumab in an Asian population with moderate‐to‐severe persistent asthma | |
| Kalyoncu et al. | Occurrence of allergic conditions in asthmatics with analgesic intolerance | |
| Sparrow et al. | Prednisolone versus dexamethasone in croup: a randomised equivalence trial | |
| US20200129471A1 (en) | Use of cannabis to treat fibromyalgia, methods and compositions thereof | |
| Silver et al. | Long-term effects of rivastigmine capsules in patients with traumatic brain injury | |
| Ramacciotti et al. | Dipyrone for acute primary headaches | |
| Gorelick | Cannabis-related disorders and toxic effects | |
| Hutt et al. | Treatment of canine generalized demodicosis using weekly injections of doramectin: 232 cases in the USA (2002–2012) | |
| Honan | Paradoxical reaction to midazolam and control with flumazenil | |
| Hermush et al. | Effects of rich cannabidiol oil on behavioral disturbances in patients with dementia: A placebo controlled randomized clinical trial | |
| Gao et al. | Safety and efficacy of fremanezumab for the prevention of migraine: a meta-analysis from randomized controlled trials | |
| Cengiz et al. | Characteristics of poisoning cases in adult intensive care unit in Sanliurfa, Turkey | |
| Rieb et al. | Withdrawal-associated injury site pain (WISP): a descriptive case series of an opioid cessation phenomenon | |
| Klotz et al. | Scorpion stings and antivenom use in Arizona | |
| Rossella et al. | Topical clonazepam for burning mouth syndrome: Is it efficacious in patients with anxiety or depression? | |
| Zamani et al. | Strategies for the treatment of acute benzodiazepine toxicity in a clinical setting: the role of antidotes | |
| Apostol et al. | Divalproex sodium extended‐release for the prophylaxis of migraine headache in adolescents: Results of a stand‐alone, long‐term open‐label safety study | |
| Klega et al. | Stimulant and designer drug use: primary care management |